SavedAdd your journal

Journals / Ulusal Cerrahi Dergisi / 2016 / Cilt: 32 - Sayı: 3

Evolution of management in peritoneal surface malignancies

Emel CANBAY
Bahar TORUN CANBAY
Ege Sinan TORUN
Yutaka YONEMURA
Pages
203–207
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Management of peritoneal surface malignancies with this current trend is presented in this review.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Management of peritoneal surface malignancies has gradually evolved by the introduction of cytoreductive surgery in combination with intraperitoneal chemotherapy applications.
📊
Key Findings & Data:Selection criteria are important to reduce morbidity and mortality rates of patients who will experience minimal or no benefit from these combined treatment modalities.
💡
Conclusion & Impact:Management of peritoneal surface malignancies with this current trend is presented in this review.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Management of peritoneal surface malignancies has gradually evolved by the introduction of cytoreductive surgery in combination with intraperitoneal chemotherapy applications. Recently, peritoneal metastases of intraabdominal solid organ tumors and primary peritoneal malignancies such as peritoneal mesothelioma are being treated with this new approach. Selection criteria are important to reduce morbidity and mortality rates of patients who will experience minimal or no benefit from these combined treatment modalities. Management of peritoneal surface malignancies with this current trend is presented in this review.

🔖

Cite This Article

CANBAY, E., CANBAY, B. T., TORUN, E. S., YONEMURA, Y. (2016). Evolution of management in peritoneal surface malignancies. Ulusal Cerrahi Dergisi, Cilt: 32 - Sayı: 3, 203–207. https://ajindex.com/articles/325347

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasm and pseudomyxoma peritonei syndrome? Lancet On- col 2006
  2. [CrossRef] Levine EA, Stewart JH 4th, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperther- mic chemotherapy for peritoneal surface malignancy: Experi- ence with 501 procedures. J Am Coll Surg 2007
  3. [CrossRef] Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with periopera- tive intraperitoneal chemotherapy for diffuse malignancy perito- neal mesothelioma. Ann Oncol 2007
  4. [CrossRef] Koppe MJ, Boerman OC, Oyen WJG, Bleichrodt RP. Peritoneal car- cinomatosis of colorectal origin. Ann Surg 2006
  5. [CrossRef] Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002
  6. [CrossRef] Cao Y, Tan A, Gao F, Liu L, Liao C, Mo Z. A meta-analysis of ran- domized controlled trials comparing chemotherapy plus bevaci- zumab with chemotherapy alone in metastatic colorectal cancer. Int J Colorectal Dis 2009
  7. [CrossRef] Klaver YL, Simkens LH, Lemmens VE, Koopman M, Teerenstra S, Bleichrodt RP, et al. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol 2012
  8. [CrossRef] Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, et al. Treatment of colorectal peritoneal carcinomatosis with sys- temic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 2012
  9. [CrossRef] Pilati P, Mocellin S, Rossi CR, Foletto M, Campana L, Nitti D, et al. Cytoreductive surgery combined with hyperthermic intraperito- neal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003
  10. [CrossRef] Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with periop- erative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-insti- tutional study. J Clin Oncol 2004
  11. [CrossRef] Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia and attempted cyto- reductive surgery in patients with peritoneal carcinomatosis of colorectal o